moxalactam has been researched along with Infection in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berk, SL; Verghese, A | 1 |
Lascola, RJ; Reitberg, DP; Schentag, JJ; Van Tyle, JH; Walczak, P; Wels, PB | 1 |
Gillissen, G | 1 |
Alanis, A; Rehm, S; Weinstein, AJ | 1 |
De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW | 1 |
Baxter, JG; Marble, DA; Schentag, JJ; Walczak, P; Wels, PB; Whitfield, LR | 1 |
4 trial(s) available for moxalactam and Infection
Article | Year |
---|---|
A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis.
Topics: Abdomen; Adult; Age Factors; Aged; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infections; Male; Middle Aged; Moxalactam; Nutrition Disorders; Prognosis; Random Allocation; Staphylococcal Infections; Staphylococcus; Tobramycin | 1983 |
Comparative efficacy and toxicity of moxalactam and the combination of nafcillin and tobramycin in febrile granulocytopenic patients.
Topics: Agranulocytosis; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Infections; Male; Moxalactam; Nafcillin; Prospective Studies; Random Allocation; Tobramycin | 1983 |
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation | 1986 |
Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin.
Topics: Abdomen; Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Factors; Clindamycin; Drug Combinations; Female; Hemorrhage; Humans; Infections; Male; Middle Aged; Moxalactam; Partial Thromboplastin Time; Prospective Studies; Prothrombin Time; Random Allocation; Risk; Tobramycin; Vitamin K | 1985 |
2 other study(ies) available for moxalactam and Infection
Article | Year |
---|---|
Moxalactam/amikacin versus ticarcillin/amikacin in granulocytopenic patients.
Topics: Agranulocytosis; Amikacin; Cephalosporins; Cephamycins; Drug Therapy, Combination; Humans; Infections; Kanamycin; Moxalactam; Penicillins; Ticarcillin | 1983 |
Non-specific influence of antibiotics on the course of infectious processes.
Topics: Animals; Anti-Bacterial Agents; Antibody Formation; Candidiasis; Cefotaxime; Cefoxitin; Cephamycins; Cyclophosphamide; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Infections; Male; Mice; Mice, Inbred BALB C; Moxalactam; Theophylline | 1982 |